Global Small Animal Molecular Imaging System Market Strategic Research Report

Scope of the Report

The global Small Animal Molecular Imaging System market size is predicted to grow from US$ 119 million in 2025 to US$ 184 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Small animal molecular imaging systems are preclinical research devices used for non-invasive, dynamic, and quantitative imaging of experimental animals such as mice and rats in vivo. Using imaging technologies such as bioluminescence, fluorescence, radionuclides (PET/SPECT), micro-CT, or micro-MRI, these systems visualize and track biological processes at the molecular, cellular, and gene expression levels. Widely used in tumor development, drug metabolism and efficacy evaluation, target validation, transgenic animal research, and precision medicine basic research, these systems are characterized by high sensitivity, repeatable monitoring, and reduced animal usage, making them a core experimental platform in drug development and life science research.

The small animal molecular imaging system industry chain consists of three main segments: upstream core components and technologies, midstream system integration and equipment manufacturing, and downstream research and application scenarios. The upstream segment mainly includes high-sensitivity detectors (CCD/EMCCD, PMT, SiPM), radioactive detection modules, magnet systems, X-ray sources, lasers and optical components, and image reconstruction and analysis algorithms, which have high technological barriers. The midstream segment consists of small animal molecular imaging system manufacturers, responsible for the integration of multi-modal imaging systems (optical, PET/SPECT, micro-CT, micro-MRI), software platform development, and performance optimization, representing the highest value-added segment of the industry chain. The downstream segment mainly serves pharmaceutical companies, CROs, universities and research institutions, and biotechnology companies, for drug development, oncology and translational medicine research, molecular probe validation, and preclinical imaging experiments. The industry as a whole exhibits characteristics of being technology-driven, research-demand oriented, and characterized by the synergistic development of equipment and software.

In 2025, the average price of a small animal molecular imaging system is projected to be US$208 k per unit, with sales of 588 units and a total production capacity of 850 units, and a gross profit margin of approximately 38%.

Global key Small Animal Molecular Imaging System players cover Perkin Elmer, Canon Medical Systems, Bruker, Idexx Laboratories, Hallmarq Veterinary Imaging, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Small Animal Molecular Imaging System market?

What factors are driving Small Animal Molecular Imaging System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Small Animal Molecular Imaging System market opportunities vary by end market size?

How does Small Animal Molecular Imaging System break out by Type, by Application?

This report presents a comprehensive overview of the global Small Animal Molecular Imaging System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Optical Imaging
• MRI
• Ultrasound
• Others

Segment by Automation Level

• Basic Imaging System
• Semi-Automatic Imaging System

Segment by System Integration Form

• Single-Modal Imaging System
• Multi-Modal Imaging System

Segment by Application

• Laboratory
• Pet Hospital and Clinic

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Small Animal Molecular Imaging System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Laboratory, Pet Hospital and Clinic evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact